tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Moleculin Biotech Holds 2025 Annual Stockholders Meeting
PremiumCompany AnnouncementsMoleculin Biotech Holds 2025 Annual Stockholders Meeting
11d ago
Moleculin Biotech Releases New Corporate Presentation
Premium
Company Announcements
Moleculin Biotech Releases New Corporate Presentation
11d ago
Promising Outlook for Moleculin Biotech Amidst Phase 3 Trial Progress and Strong Financial Position
Premium
Ratings
Promising Outlook for Moleculin Biotech Amidst Phase 3 Trial Progress and Strong Financial Position
15d ago
Moleculin Biotech (MBRX) Q2 Earnings Cheat Sheet
PremiumPre-EarningsMoleculin Biotech (MBRX) Q2 Earnings Cheat Sheet
19d ago
Moleculin Biotech Reveals Promising Preclinical Data for Annamycin
Premium
Company Announcements
Moleculin Biotech Reveals Promising Preclinical Data for Annamycin
23d ago
Moleculin Biotech announces preclinical data of annamycin in liver cancer
Premium
The Fly
Moleculin Biotech announces preclinical data of annamycin in liver cancer
23d ago
Moleculin Biotech appoints Adriano Treve as strategic advisor
PremiumThe FlyMoleculin Biotech appoints Adriano Treve as strategic advisor
1M ago
Moleculin Biotech Enters New Stock Offering Agreement
Premium
Company Announcements
Moleculin Biotech Enters New Stock Offering Agreement
2M ago
Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
Premium
Ratings
Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100